{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:25:40Z","timestamp":1747164340832,"version":"3.40.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jdermsci.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T18:12:41Z","timestamp":1467915161000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis"],"prefix":"10.1016","volume":"84","author":[{"given":"Anna","family":"G\u00f6r\u00f6g","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriszti\u00e1n","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1lma","family":"Sill\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-004X","authenticated-orcid":false,"given":"Krasimir","family":"Kolev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.07.005_bib0005","first-page":"184","article-title":"Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring","volume":"37","author":"Karpati","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.iac.2012.04.005","article-title":"An exception within the group of autoimmune blistering diseases: dermatitis herpetiformis the gluten-sensitive dermopathy","volume":"32","author":"K\u00e1rp\u00e1ti","year":"2012","journal-title":"Immunol. Allergy Clin. North. Am."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"S\u00e1rdy","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0020","first-page":"441","article-title":"Papillary fibrin in dermatitis herpetiformis","volume":"26","author":"Mustakallio","year":"1970","journal-title":"Arch. Belg. Dermatol. Syphiligr."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0025","first-page":"19","article-title":"Papillary deposition of fibrin in iodide reactions in dermatitis herpetiformis","volume":"2","author":"Salo","year":"1970","journal-title":"Ann. Clin. Res."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0030","first-page":"167","article-title":"Deposition of fibrin-like material in early lesions of dermatitis herpetiformis","volume":"105","author":"Jakubowicz","year":"1981","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.1981.tb01202.x","article-title":"Inflammatory cells, IgA C3, fibrin and fibronectin in skin lesions in dermatitis herpetiformis","volume":"105","author":"Reitamo","year":"1981","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/jid.2014.368","article-title":"Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen","volume":"135","author":"Taylor","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0045","article-title":"High prevalence of cryofibrinogenemia in dermatitis herpetiformis","author":"Bogn\u00e1r","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0050","first-page":"463","article-title":"New clinical approach in treatment of cryofibrinogenemia \u2013 diamino-diphenyl-sulfone seems to decrease the amount of cold precipitated serum-proteins-in vitro","volume":"109","author":"Karpati","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2011.11.040","article-title":"Factor XIII clot structure, thrombosis","volume":"129","author":"Bagoly","year":"2012","journal-title":"Thromb. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.jdermsci.2016.07.005_bib0060","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.thromres.2012.02.040","article-title":"Factor XIII and inflammatory cells","volume":"129","author":"Bagoly","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/156801605774322337","article-title":"Fibrinolysis at the fluid-solid interface of thrombi","volume":"3","author":"Kolev","year":"2005","journal-title":"Curr. Med. Chem. Cardiovasc. Hematol. Agents"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0070","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/jth.12935","article-title":"Basic mechanisms and regulation of fibrinolysis","volume":"13","author":"Longstaff","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0037-1613031","article-title":"Immunglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin","volume":"87","author":"Kolev","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2010-06-290338","article-title":"The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies","volume":"117","author":"Longstaff","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0049-3848(94)90227-5","article-title":"Fibrin in human plasma: gel architecture governed by rate and nature of fibrinogen activation","volume":"75","author":"Blomback","year":"1994","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-2143(96)90116-X","article-title":"Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma","volume":"128","author":"Carr","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003088-198611040-00003","article-title":"Clinical pharmacokinetics of dapsone","volume":"11","author":"Zuidema","year":"1986","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0100","series-title":"Theory and Applications of Monte Carlo Simulations","first-page":"1","article-title":"Monte Carlo statistical tests for identity of theoretical and empirical distributions of experimental data","author":"Nikolova","year":"2013"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2133.1991.tb03284.x","article-title":"Induction of lesions of dermatitis herpetiformis by autologous serum","volume":"124","author":"Cox","year":"1991","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.1963.tb15687.x","article-title":"The treatment of dermatitis herpetiformis with heparin","volume":"75","author":"Alexander","year":"1963","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000246356","article-title":"A rare case of dermatitis herpetiformis requiring parenteral heparin for long-term control","volume":"192","author":"Tan","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2230.2000.00615.x","article-title":"Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide","volume":"25","author":"Shah","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0125","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1074\/jbc.M112.404301","article-title":"Mechanical stability and fibrinolytic resistance of clots containing fibrin DNA, and histones","volume":"288","author":"Longstaff","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH14-08-0669","article-title":"DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment","volume":"113","author":"Varj\u00fa","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0135","doi-asserted-by":"crossref","first-page":"e41966","DOI":"10.1371\/journal.pone.0041966","article-title":"Identification of fibrin clot-bound plasma proteins","volume":"7","author":"Talens","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapson in dermatology and beyond","volume":"306","author":"Wozel","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","article-title":"Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease","volume":"171","author":"Marzano","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2016.07.005_bib0155","first-page":"189","article-title":"Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis","volume":"8","author":"Wankiewicz","year":"2002","journal-title":"Med. Sci. Monit."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T17:38:21Z","timestamp":1568137101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116301517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0923181116301517"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.07.005","relation":{},"ISSN":["0923-1811"],"issn-type":[{"type":"print","value":"0923-1811"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}